Kiandokht Keyhanian, MD
Neurology · Secaucus, NJNPI 1508398546
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $13,170 of the $19,138 with a category attached, or 68.8%. AstraZeneca accounts for 67.5% of it on its own, with 16 other manufacturers making up the rest. 2025 is the largest year on record at $14,012, more than ten times the $175 reported in 2022.
Across 177 payments — averaging $108.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$13K
- Amgen$3K
- EMD Serono, Inc.$889
- Biogen$658
- Bristol Myers Squibb$399
- Novartis$308
- plus $931 from 11 others
What the payments were for
- Speaking & faculty fees$13,17069%
- Travel & lodging$1,0435%
- Food & beverage$4,86225%
- Education$630%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 30 | $12,915 |
| Amgen(2 entities) | 22 | $3,038 |
| EMD Serono, Inc. | 17 | $889 |
| Biogen | 21 | $658 |
| Bristol Myers Squibb | 40 | $399 |
| Novartis | 15 | $308 |
| Genentech USA, Inc. | 12 | $230 |
| TG Therapeutics, Inc. | 3 | $171 |
| Medtronic | 1 | $143 |
| E.r. Squibb & Sons, L.L.C. | 2 | $143 |
| Teva Pharmaceuticals USA, Inc. | 5 | $82 |
| Lilly USA, LLC | 3 | $47 |
| Springworks Therapeutics, Inc. | 2 | $38 |
| Philips North America LLC | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Axonics, Inc. | 1 | $19 |
| AbbVie | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$19,138 in reported general payments places this provider in the 80th percentile of 521 neurology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Secaucus
- Antwan AhadSecaucus$44K
- Steven BromleyAudubon$1.5M
- Mary Ann PiconeTeaneck$1.5M
- Fiona GuptaOradell$1.1M
- Matthew DavisMiddletown$567K
- Amos KatzEatontown$558K
- Monte PellmarFreehold$429K
- Marcie RabinSummit$387K
- Ashish KapoorBayonne$329K
- Mario VukicHackensack$310K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.